Your browser doesn't support javascript.
loading
GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.
Perez-Fidalgo, J Alejandro; Iglesias, Maria; Bohn, Uriel; Calvo, Elisa; Garcia, Yolanda; Guerra, Eva; Manso, Luis; Santaballa, Ana; Gonzalez-Martin, Antonio.
Afiliação
  • Perez-Fidalgo JA; Department of Medical Oncology, Hospital Clinico Universitario de Valencia, CIBERONC, Spain.
  • Iglesias M; Department of Medical Oncology, Hospital Clinico Universitario de Valencia, CIBERONC, Spain.
  • Bohn U; Department of Medical Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
  • Calvo E; Department of Medical Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
  • Garcia Y; Department of Medical Oncology, Hospital Universitario Dr Negrin, Las Palmas de Gran Canaria, Spain.
  • Guerra E; Department of Medical Oncology, Hospital Universitario Dr Negrin, Las Palmas de Gran Canaria, Spain.
  • Manso L; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Santaballa A; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Gonzalez-Martin A; Department of Medical Oncology, Hospital Universitario Parc Tauli, Sabadell, Spain.
Future Sci OA ; 5(2): FSO370, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30820349

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article